Literature DB >> 23581135

Medical training using simulation: toward fewer animals and safer patients.

Jonathan Balcombe1.   

Abstract

This paper presents the current status of computer-based simulation in medicine. Recent technological advances have enabled this field to emerge from esoteric explorations in academic laboratories to commercially available simulators designed to train users to perform medical procedures from start to finish. Today, more than a dozen companies are producing virtual reality simulators and interactive manikins for training in endoscopy, laparoscopy, anaesthesia, trauma management, angiography, and needle insertion. For many of these procedures, thousands of animals are still being used in training. Yet simulation has many advantages that can transcend scientific, ethical, economic and logistical problems that arise when using animals. The first validation studies of medical simulators began appearing in the late 1990s, and the early results indicate that these devices measure what they are intended to, and that they can improve performance relative to traditional learning methods. In addition to expanded use for new and existing minimally invasive procedures, medical simulators will probably soon be used in physician credentialing, and they may someday allow surgeons to rehearse procedures in a patient-specific operating environment. Replacing animals with simulators in medical training is limited no longer by technical feasibility but by a willingness of the medical community to embrace it.

Entities:  

Mesh:

Year:  2004        PMID: 23581135     DOI: 10.1177/026119290403201s90

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  1 in total

1.  Virtual Reality simulator for dental anesthesia training in the inferior alveolar nerve block.

Authors:  Cléber Gimenez Corrêa; Maria Aparecida de Andrade Moreira Machado; Edith Ranzini; Romero Tori; Fátima de Lourdes Santos Nunes
Journal:  J Appl Oral Sci       Date:  2017 Jul-Aug       Impact factor: 2.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.